30% Of Koreans Self-Medicate With Rx Drugs

20 January 1997

In Korea, where most prescription-only medicines can be bought inpharmacies without presenting a script, people buying Rx drugs in this way account for around 30% of the total, according to a survey by Lee Kihyo, a professor at Inje University graduate school of public health, and Yang Jin-son, a pharmacist at the Pusan Kangso ward health center.

The survey included 647 people, including students at high schools and children at an elementary school, and their parents, states a report in Korea Newsreview. The rate of self-prescription was higher among people living in fishing and agrarian villages, with some 53.3% saying they did not seek professional medical advice when buying their medicines.

More than 40% of those surveyed said they chose to prescribe their own medicine as their symptoms were mild, and around 26% were of the view that it was safe and effective to do this. Around 5% believed that it would cost more to have pharmacists write out a prescription.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight